- Home
- TMO
as 07-31-2025 10:00am EST
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year end-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (54%).
| Founded: | 1956 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 159.1B | IPO Year: | N/A |
| Target Price: | $587.65 | AVG Volume (30 days): | 3.2M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 17.30 | EPS Growth: | 7.24 |
| 52 Week Low/High: | $385.46 - $627.88 | Next Earning Date: | 07-23-2025 |
| Revenue: | $43,212,000,000 | Revenue Growth: | 2.04% |
| Revenue Growth (this year): | 2.96% | Revenue Growth (next year): | 6.01% |
Latest Thermo Fisher Scientific Inc News
TMO Breaking Stock News: Dive into TMO Ticker-Specific Updates for Smart Investing
Insider Monkey
2 hours ago
Here’s Why Thermo Fisher Scientific (TMO) Traded Down in Q2
GlobeNewswire
5 hours ago
Systemic Lupus Erythematosus Clinical Trials Market Landscape Report 2025 Featuring GSK, BMS, AstraZeneca, Thermo Fisher Scientific, ICON, IQVIA, Parexel, Laboratory Corp of America, Novartis, Pfizer
GlobeNewswire
5 hours ago
Sicca Syndrome (Sjogren) Clinical Trials Market Landscape Report 2025 Featuring Novartis, BMS, ICON, AbbVie, Parexel, Thermo Fisher Scientific, Amgen, Laboratory Corp of America, IQVIA, Syneos Health
GlobeNewswire
a day ago
Pharma Formulation Development Outsourcing Forecast Report 2025-2033 Featuring SGS, Intertek, Recipharm, Lonza, Charles River Laboratories, Eurofins Scientific, Labcorp, Thermo Fisher Scientific
GlobeNewswire
a day ago
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic
StockStory
a day ago
5 Insightful Analyst Questions From Thermo Fisher’s Q2 Earnings Call
GlobeNewswire
2 days ago
Failure Analysis Market Forecasts Report 2025-2030 | Rising RCA Demand, FIB Innovations, and Industry-Wide Quality Control Priorities Driving Growth
PR Newswire
2 days ago
ADLM announces 2025 Top Corporate Supporter Award recipients and thanks them for their vital backing
Compare TMO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TMO Thermo Fisher Scientific Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.